Health Awareness
Neurological Health 2021
-
Severe strokes & COVID-19: What’s the link?
Stroke Awareness Month took place during May and this year’s campaign focused on raising awareness of the damaging effects of the COVID-19 pandemic on stroke research. Now, a report from the COVID-19 Stroke Study Group has found an association between COVID-19 and more severe strokes, as well as strokes in younger people. Widespread increase in...
-
Challenges and opportunities for improved mental health
About 10% of the population in Europe has been reported to suffer from a mental disorder requiring treatment. The estimated number is even higher.1 About a third of European patients with mental disorders that require treatment have had an unfavourable outcome, leading to reduced functional capacity in their work and social lives. Reasons for this...
-
Hopes of treatment rise for dementia patients at young age
Frontotemporal dementia is an early-onset disease striking patients in their 50s and 60s with devastating outcomes. Frontotemporal dementia (FTD) is a rare hereditary disease which progresses rapidly in patients. There is no recognised treatment for FTD, though a number of clinical trials for therapies are showing promise. Neurologist John van Swieten, who is Professor in...
-
A new 21st century stewardship for brain health
To substantially improve the lives of those with mental and neurological health conditions, we must rethink how we conduct and fund brain health research. A global health crisis Throughout our lifetime, one in every four people1 will suffer from a mental health condition and one in every three2 will experience a neurological condition. Overall, brain...
-
s Sponsored
Psychedelic drugs being adapted for mental health care
New treatments for patients with depression or addiction are being developed from psychedelic drugs. Second-generation psychedelic drugs are being developed to create new therapies for people suffering from depression or addiction. While still undergoing trials, specialists believe these medications can be an alternative to long-standing anti-depressives. Doug Drysdale, who heads one of the companies that...
-
s Sponsored
Quest to combat rare form of dementia
Scientists are embracing a therapeutic concept used in oncology to find a treatment for a rare form of dementia. Frontotemporal dementia (FTD) is a rare disease unlike Alzheimer’s disease but runs in families and has a similar deep impact on patients and their families. With no recognised disease-modifying treatment, FTD has become a focus for an...
-
The importance of continued psychedelic research
Medical psychedelic research has undergone a renaissance recently1. Studies have shown a remarkable response in neurological and hard to treat mental health conditions. Psychedelics include plant medicines such as psilocybin (the active constituent of magic mushrooms), Ayahuasca (a South American psychoactive brew containing DMT,N-dimethyltryptamine-and monoamine oxidase inhibitors, often consumed as a tea), mescaline (from the...
-
The time has come to prioritise neurology as one
Neurological disorders exert the highest toll measured as disease burden. We need a comprehensive framework to address them collectively. There are more than 400 neurological disorders, including cerebrovascular diseases and neurodegenerative diseases. Neurological disorders have the highest prevalence, biggest disability and the greatest cost among chronic disorders. They are also the fastest growing cause of...
-
Patient care and innovation in health policy
The UK is experiencing a health care revolution driven by digital and data, promising to transform the way that we are able to diagnose, treat and cure disease. The COVID-19 pandemic placed the health service under the greatest pressure in its history. It also acted as a catalyst, increasing the agility of services, embedding innovation...
-
Long-COVID: the next crisis in mental health?
Over 4 million people in the UK and over 150 million people worldwide have now been infected by COVID-19. As a result, long-COVID is now becoming an emerging problem. Thankfully, most who catch COVID-19 make a full recovery within days, but some who survive their initial illness go on to experience long-lasting and debilitating symptoms...
-
Emerging treatments for migraine
Migraine is the second leading cause of disability worldwide, impacting an estimated one billion people globally. In the last five years a new wave of treatments have come to market in the United States, and some in other places in the world, that have revolutionised migraine treatment. Six of these new treatments are medications that...
